Report overview
Companion Animal Specialty Drug is a kind of veterinary drugs that pet owners used to treatment and care of animals.
This report aims to provide a comprehensive presentation of the global market for Companion Animal Specialty Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Specialty Drugs. This report contains market size and forecasts of Companion Animal Specialty Drugs in global, including the following market information:
Global Companion Animal Specialty Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Companion Animal Specialty Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Companion Animal Specialty Drugs companies in 2022 (%)
The global Companion Animal Specialty Drugs market was valued at US$ 12890 million in 2022 and is projected to reach US$ 17370 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Americas has the presence of large veterinary markets such as the US and Canada. The companion animal specialty drugs market is witnessing continuous growth in the region due to the rising awareness and the availability of companion animal healthcare. Furthermore, the increase in disposable incomes of pet owners and economic development, will also contribute to the growth of the market in this region.
We surveyed the Companion Animal Specialty Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Animal Specialty Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Companion Animal Specialty Drugs Market Segment Percentages, by Type, 2022 (%)
Vaccines
Antibiotics
Parasiticides
Feed Additives
Other
Global Companion Animal Specialty Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Companion Animal Specialty Drugs Market Segment Percentages, by Application, 2022 (%)
Veterinary Hospitals
Pet Care Clinics
Pharmacy Stores
Global Companion Animal Specialty Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Companion Animal Specialty Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Animal Specialty Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Companion Animal Specialty Drugs revenues share in global market, 2022 (%)
Key companies Companion Animal Specialty Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Companion Animal Specialty Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Elanco
Merial
Zoetis
Aratana therapeutics
Beaphar
Henry Schein
Mars
The J.M Smucker Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Companion Animal Specialty Drugs, market overview.
Chapter 2: Global Companion Animal Specialty Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Companion Animal Specialty Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Companion Animal Specialty Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Companion Animal Specialty Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
